Copanlisib Approved for Follicular Lymphoma

FDA has granted accelerated approval to copanlisib (Aliquopa®) for the treatment of patients with follicular lymphoma, a form of non-Hodgkin lymphoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2xJ2yMV
via IFTTT